🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome

RecruitingNAAges 18 Years - anyAllMedical University Innsbruck
NCT07391683 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide levels and postoperative outcomes, patients at increased risk could be identified using this biomarker. Telemedical disease management programs have demonstrated efficacy in outpatient heart failure care, but their role in preoperative optimization remains underexplored. This study aims to assess whether a structured, multidisciplinary, telemedicine-assisted prehabilitation program can reduce perioperative complications, and improve surgical outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Indication for elective cardiac surgery in the Heart team * NTproBNP ≥ 1500 ng/L * ≥ 18 years willing to participate in trial * Written informed consent Exclusion Criteria: * Neuropsychiatric disorders / illnesses (e.g. drug addiction, alcohol abuse) that do not allow adherent participation in the study * No sufficient ability to measure and transfer data or existing support in the social environment * no sufficient ability to communicate (language skills, eyesight, hearing) * Pregnancy * Chronic kidney disease requiring dialysis * Planed procedure: heart transplantation (HTX), implant of left ventricular mechanical assist devices (L-VAD)
💊

What it tests

  • PREPARE-HF disease management program, which includes:
📍

Where

1 site
Medical University of Innsbruck - Department of Cardiology & Department of Cardiac Surgery
Innsbruck, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy